American Registry of Ambulatory or Acutely Decompensated Heart Failure (NCT05295641) | Clinical Trial Compass
CompletedNot Applicable
American Registry of Ambulatory or Acutely Decompensated Heart Failure
United States, Argentina, Bolivia6,732 participantsStarted 2022-04-01
Plain-language summary
The purpose of this study is to better characterize and understand the population of patients with ambulatory or acutely decompensated heart failure in the American continent, getting to know their sociodemographic, clinical and paraclinical characteristics
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient aged 18 years or older and one of the following:
* Hospitalized patient with admission diagnosis of acutely decompensated heart failure or
* Outpatient with confirmed diagnosis (main or complementary) of heart failure
Exclusion Criteria:
* Hospitalized patient with principal diagnosis of another cardiovascular / non-cardiovascular pathology and who develops an acute decompensation of heart failure during hospitalization.
* Patient on heart transplant waiting list
* Patient who has implanted or is in process of implanting a long-term ventricular assist device (eg, Heart Mate II, Heart Mate III) as a target therapy or bridge therapy to other therapies
* Patient in whom palliative management has been previously defined for his/her cardiac condition (i.e. Heart failure) or for another associated medical condition (cancer, chronic obstructive pulmonary disease (COPD), etc.)
* Patient who is discharged or referred to another institution within 48 hours of hospital stay
* Inability to comply with programmed follow-ups (telephone or in person) due to social, personal or other conditions considered by the principal investigator
* Life expectancy less than 6 months given a condition other than heart failure (Cancer, COPD, etc.)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this registry is focused on collecting data about people with heart failure in America rather than testing a new treatment, what would actually be different about my care if I had participated — and are there similar observational studies still open that I could join?
2This study has already completed enrollment, so I can't join it — but could the data being gathered here influence which treatments or management approaches my care team might consider for my specific type of heart failure, whether ambulatory or acutely decompensated?
3Because this was a registry study rather than a clinical trial testing a drug or device, it wasn't designed to directly benefit participants — so what are the current standard-of-care options you'd recommend for someone at my stage of heart failure while we wait for findings like these to shape future guidelines?
4The registry tracked both people managing heart failure at home and those hospitalized with acute decompensation — given where I am right now, which of those groups does my situation most resemble, and how does that affect the urgency of my treatment plan?
5Are there any active trials or registries enrolling now that are similar to this one, where my participation could contribute to understanding heart failure patterns while also giving me access to closer monitoring or specialized care?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Characteristics of population with diagnosis of heart failure in America
Timeframe: Baseline
2
Characteristics of population with diagnosis of heart failure in America
Timeframe: Baseline, at Month 1, Month 6 and Month 12